Current and emerging imaging techniques in the diagnosis and assessment of pulmonary hypertension

References

• Galiè N, Humbert M, Vachiery J-L, et al. 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: the joint task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS) . Endor Eur Heart J. 2016;37:67–119.
   PubMed Web of Science ®Google Scholar
• Kiely DG, Elliot CA, Sabroe I, et al. Pulmonary hypertension: diagnosis and management. BMJ. 2013;346:f2028–f2028.
   PubMedGoogle Scholar
• Rajaram S, Swift AJ, Wild JM, et al. Response to: ‘CT assessment for pulmonary hypertension requires systematic assessment of cardiac, vascular and parenchymal signs’ by Marloes et al.. Thorax. 2015; thoraxjnl-2015-207394.
   Web of Science ®Google Scholar
• Avouac J, Airò P, Meune C, et al. Prevalence of pulmonary hypertension in systemic sclerosis in European Caucasians and metaanalysis of 5 studies. J Rheumatol. 2010;37:2290–2298.
   PubMed Web of Science ®Google Scholar
• Mandell MS, Groves BM. Pulmonary hypertension in chronic liver disease. Clin Chest Med. 1996;17:17–33.
   PubMed Web of Science ®Google Scholar
• Budhiraja R, Hassoun PM. Portopulmonary hypertension: a tale of two circulations. Chest. 2003;123:562–576.
   PubMed Web of Science ®Google Scholar
• Castro M, Krowka MJ, Schroeder DR, et al. Frequency and clinical implications of increased pulmonary artery pressures in liver transplant patients. Mayo Clin Proc. 1996;71:543–551.
   PubMed Web of Science ®Google Scholar
• Sitbon O, Lascoux-Combe C, Delfraissy J-F, et al. Prevalence of HIV-related pulmonary arterial hypertension in the current antiretroviral therapy era. Am J Respir Crit Care Med. 2008;177:108–113.
   PubMed Web of Science ®Google Scholar
• Rich S, Dantzker DR, Ayres SM, et al. Primary pulmonary hypertension. a national prospective study. Ann Intern Med. 1987;107:216–223.
   PubMed Web of Science ®Google Scholar
• Galie N, Hoeper MM, Humbert M, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: the task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the Internat. Eur Heart J. 2009;30:2493–2537.
   PubMed Web of Science ®Google Scholar
• Currie PJ, Seward JB, Chan KL, et al. Continuous wave Doppler determination of right ventricular pressure: a simultaneous Doppler-catheterization study in 127 patients. J Am Coll Cardiol. 1985;6:750–756.
   PubMed Web of Science ®Google Scholar
• Berger M, Haimowitz A, Van Tosh A, et al. Quantitative assessment of pulmonary hypertension in patients with tricuspid regurgitation using continuous wave Doppler ultrasound. J Am Coll Cardiol. 1985;6:359–365.
   PubMed Web of Science ®Google Scholar
• Fisher MR, Forfia PR, Chamera E, et al. Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertension. Am J Respir Crit Care Med. 2009;179:615–621.
   PubMed Web of Science ®Google Scholar
• Parasuraman S, Walker S, Loudon B, et al. Assessment of pulmonary artery pressure by echocardiography—a comprehensive review. Int J Cardiol Hear Vasc. 2016;12:45–51.
   PubMed Web of Science ®Google Scholar
• Kiely DG, Cargill RI, Struthers AD, et al. Cardiopulmonary effects of endothelin-1 in man. Cardiovasc Res. 1997;33:378–386.
   PubMed Web of Science ®Google Scholar
• Ommen SR, Nishimura RA, Appleton CP, et al. Clinical utility of doppler echocardiography and tissue doppler imaging in the estimation of left ventricular filling pressures : a comparative simultaneous Doppler-catheterization study. Circulation. 2000;102:1788–1794.
   PubMed Web of Science ®Google Scholar
• Nanthakumar K, Graham AT, Robinson TI, et al. Contrast echocardiography for detection of pulmonary arteriovenous malformations. Am Heart J. 2001;141:243–246.
   PubMed Web of Science ®Google Scholar
• Attaran RR, Ata I, Kudithipudi V, et al. Protocol for optimal detection and exclusion of a patent foramen ovale using transthoracic echocardiography with agitated saline microbubbles. Echocardiography. 2006;23:616–622.
   PubMed Web of Science ®Google Scholar
• Silvestry FE, Cohen MS, Armsby LB, et al. Guidelines for the echocardiographic assessment of atrial septal defect and patent foramen ovale: from the american society of echocardiography and society for cardiac angiography and interventions. J Am Soc Echocardiogr. 2015;28:910–958.
   PubMed Web of Science ®Google Scholar
• Bajc M, Neilly JB, Miniati M, et al. EANM guidelines for ventilation/perfusion scintigraphy: part 1. Pulmonary imaging with ventilation/perfusion single photon emission tomography. Eur J Nucl Med Mol Imaging. 2009;36:1356–1370.
   PubMed Web of Science ®Google Scholar
• Johns CS, Swift AJ, Rajaram S, et al. Lung perfusion: MRI vs. SPECT for screening in suspected chronic thromboembolic pulmonary hypertension. J Magn Reson Imaging. 2017 Dec;46(6):1693–1697.
   Web of Science ®Google Scholar
• Johns CS, Swift AJ, Hughes PJC, et al. Pulmonary MR angiography and perfusion imaging—a review of methods and applications. Eur J Radiol. 2017;86:361–370.
   PubMed Web of Science ®Google Scholar
• Rajaram S, Swift AJ, Telfer A, et al. 3D contrast-enhanced lung perfusion MRI is an effective screening tool for chronic thromboembolic pulmonary hypertension: results from the ASPIRE registry. Thorax. 2013;68:677–678.
   PubMed Web of Science ®Google Scholar
• Hagan G, Southwood M, Treacy C, et al. (18)FDG PET imaging can quantify increased cellular metabolism in pulmonary arterial hypertension: a proof-of-principle study. Pulm Circ. 2011;1:448–455.
   PubMedGoogle Scholar
• Fang W, Zhao L, Xiong C-M, et al. Comparison of 18F-FDG uptake by right ventricular myocardium in idiopathic pulmonary arterial hypertension and pulmonary arterial hypertension associated with congenital heart disease. Pulm Circ. 2012;2:365–372.
   PubMedGoogle Scholar
• Zhao L, Ashek A, Wang L, et al. Heterogeneity in lung 18FDG uptake in pulmonary arterial hypertension: potential of dynamic 18FDG positron emission tomography with kinetic analysis as a bridging biomarker for pulmonary vascular remodeling targeted treatments. Circulation. 2013;128:1214–1224.
   PubMed Web of Science ®Google Scholar
• Tatebe S, Fukumoto Y, Oikawa-Wakayama M, et al. Enhanced [18F]fluorodeoxyglucose accumulation in the right ventricular free wall predicts long-term prognosis of patients with pulmonary hypertension: a preliminary observational study. Eur Heart J Cardiovasc Imaging. 2014;15:666–672.
   PubMed Web of Science ®Google Scholar
• Schlosser T, Nensa F, Mahabadi AA, et al. Hybrid MRI/PET of the heart: a new complementary imaging technique for simultaneous acquisition of MRI and PET data. Heart. 2013;99:351–352.
   PubMed Web of Science ®Google Scholar
• Rajaram S, Swift AJ, Davies C, et al. Primary pulmonary artery sarcoma and coexisting chronic thromboembolic pulmonary hypertension. Am J Respir Crit Care Med. 2013;188:e7–8.
   PubMed Web of Science ®Google Scholar
• David S, Hoeper MM, Vogel-Claussen J, et al. Pulmonary arterial sarcoma presenting as acute pulmonary embolism. Am J Respir Crit Care Med. 2017;196:523.
   PubMed Web of Science ®Google Scholar
• Rajaram S, Swift AJ, Condliffe R, et al. CT features of pulmonary arterial hypertension and its major subtypes: a systematic CT evaluation of 292 patients from the ASPIRE registry. Thorax. 2015;70:382–387.
   PubMed Web of Science ®Google Scholar
• Tan RT, Kuzo R, Goodman LR, et al. Utility of CT scan evaluation for predicting pulmonary hypertension in patients with parenchymal lung disease. Chest. 1998;113:1250–1256.
   PubMed Web of Science ®Google Scholar
• Edwards PD, Bull RK, Coulden R. CT measurement of main pulmonary artery diameter. Br J Radiol. 1998;71:1018–1020.
   PubMed Web of Science ®Google Scholar
• Ramjug S, Hussain N, Hurdman J, et al. Idiopathic and systemic sclerosis-associated pulmonary arterial hypertension. Chest. 2017;152:92–102.
   PubMed Web of Science ®Google Scholar
• Condliffe R, Kiely DG, Peacock AJ, et al. Connective tissue disease-associated pulmonary arterial hypertension in the modern treatment era. Am J Respir Crit Care Med. 2009;179:151–157.
   PubMed Web of Science ®Google Scholar
• Sheehan R, Perloff JK, Fishbein MC, et al. Pulmonary neovascularity: a distinctive radiographic finding in Eisenmenger syndrome. Circulation. 2005;112:2778–2785.
   PubMed Web of Science ®Google Scholar
• Dong C, Zhou M, Liu D, et al. Diagnostic accuracy of computed tomography for chronic thromboembolic pulmonary hypertension: a systematic review and meta-analysis. PLoS One. 2015;10:e0126985.
   PubMed Web of Science ®Google Scholar
• Reichelt A, Hoeper MM, Galanski M, et al. Chronic thromboembolic pulmonary hypertension: evaluation with 64-detector row CT versus digital substraction angiography. Eur J Radiol. 2009;71:49–54.
   PubMed Web of Science ®Google Scholar
• Tunariu N, Gibbs SJR, Win Z, et al. Ventilation-perfusion scintigraphy is more sensitive than multidetector CTPA in detecting chronic thromboembolic pulmonary disease as a treatable cause of pulmonary hypertension. J Nucl Med. 2007;48:680–684.
   PubMed Web of Science ®Google Scholar
• Baque-Juston MC, Wells AU, Hansell DM. Pericardial thickening or effusion in patients with pulmonary artery hypertension: a CT study. Am J Roentgenol. 1999;172:361–364.
   PubMed Web of Science ®Google Scholar
• Groves A, Win T, Charman S, et al. Semi-quantitative assessment of tricuspid regurgitation on contrast-enhanced multidetector CT. Clin Radiol. 2004;59:715–719.
   PubMedGoogle Scholar
• Horton MR, Tuder RM. Primary pulmonary arterial hypertension presenting as diffuse micronodules on CT. Crit Rev Comput Tomogr. 2004;45:335–341.
   PubMedGoogle Scholar
• Resten A, Maître S, Humbert M, et al. Pulmonary arterial hypertension: thin-section CT predictors of epoprostenol therapy failure. Radiology. 2002;222:782–788.
   PubMed Web of Science ®Google Scholar
• Revel M-P, Faivre J-B, Remy-Jardin M, et al. Pulmonary hypertension: ECG-gated 64-section CT angiographic evaluation of new functional parameters as diagnostic criteria. Radiology. 2009;250:558–566.
   PubMed Web of Science ®Google Scholar
• Thieme SF, Graute V, Nikolaou K, et al. Dual Energy CT lung perfusion imaging–correlation with SPECT/CT. Eur J Radiol. 2012;81:360–365.
   PubMed Web of Science ®Google Scholar
• Johnson TRC, Krauss B, Sedlmair M, et al. Material differentiation by dual energy CT: initial experience. Eur Radiol. 2007;17:1510–1517.
   PubMed Web of Science ®Google Scholar
• Chandra N, Langan DA. Gemstone detector: dual energy imaging via fast kVp switching. In: Johnson T, Fink C, Schönberg SO, et al. editors. Dual energy CT clinical practice. Berlin (Heidelberg): Springer Berlin Heidelberg; 2011. p. 35–41.
   Google Scholar
• Fornaro J, Leschka S, Hibbeln D, et al. Dual- and multi-energy CT: approach to functional imaging. Insights Imaging. 2011;2:149–159.
   PubMedGoogle Scholar
• Ohana M, Jeung MY, Labani A, et al. Thoracic dual energy CT: acquisition protocols, current applications and future developments. Diagn Interv Imaging. 2014;95:1017–1026.
   PubMed Web of Science ®Google Scholar
• Ameli-Renani S, Rahman F, Nair A, et al. Dual-energy CT for imaging of pulmonary hypertension: challenges and opportunities. Radiographics. 2013;34:1769–1790.
   Web of Science ®Google Scholar
• Hoey ETD, Mirsadraee S, Pepke-Zaba J, et al. Dual-energy CT angiography for assessment of regional pulmonary perfusion in patients with chronic thromboembolic pulmonary hypertension: initial experience. Am J Roentgenol. 2011;196:524–532.
   PubMed Web of Science ®Google Scholar
• Remy-Jardin M, Faivre J-B, Pontana F, et al. Thoracic applications of dual energy. Radiol Clin North Am. 2010;48:193–205.
   PubMed Web of Science ®Google Scholar
• Ruzsics B, Lee H, Zwerner PL, et al. Dual-energy CT of the heart for diagnosing coronary artery stenosis and myocardial ischemia-initial experience. Eur Radiol. 2008;18:2414–2424.
   PubMed Web of Science ®Google Scholar
• Swift AJ, Capener D, Johns CS, et al. Magnetic resonance imaging in the prognostic evaluation of patients with pulmonary arterial hypertension. Am J Respir Crit Care Med. 2017.
   Web of Science ®Google Scholar
• Swift AJ, Rajaram S, Hurdman J, et al. Noninvasive estimation of PA pressure, flow, and resistance with CMR imaging. JACC Cardiovasc Imaging. 2013;6:1036–1047.
   PubMed Web of Science ®Google Scholar
• Roeleveld RJ, Marcus JT, Boonstra A, et al. A comparison of noninvasive MRI-based methods of estimating pulmonary artery pressure in pulmonary hypertension. J Magn Reson Imaging. 2005;22:67–72.
   PubMed Web of Science ®Google Scholar
• Sanz J, Kuschnir P, Rius T, et al. Pulmonary arterial hypertension: noninvasive detection with phase-contrast MR imaging. Radiology. 2007;243:70–79.
   PubMed Web of Science ®Google Scholar
• Gan CT-J, Lankhaar J-W, Westerhof N, et al. Noninvasively assessed pulmonary artery stiffness predicts mortality in pulmonary arterial hypertension. Chest. 2007;132:1906–1912.
   PubMed Web of Science ®Google Scholar
• García-Alvarez A, Fernández-Friera L, Mirelis JG, et al. Non-invasive estimation of pulmonary vascular resistance with cardiac magnetic resonance. Eur Heart J. 2011;32:2438–2445.
   PubMed Web of Science ®Google Scholar
• Swift AJ, Rajaram S, Condliffe R, et al. Diagnostic accuracy of cardiovascular magnetic resonance imaging of right ventricular morphology and function in the assessment of suspected pulmonary hypertension results from the ASPIRE registry. J Cardiovasc Magn Reson. 2012;14:40.
   PubMed Web of Science ®Google Scholar
• Moral S, Fernández-Friera L, Stevens G, et al. New index alpha improves detection of pulmonary hypertension in comparison with other cardiac magnetic resonance indices. Int J Cardiol. 2012;161:25–30.
   PubMed Web of Science ®Google Scholar
• Johns CS, Rajaram S, Capener DA, et al. Non-invasive methods for estimating mPAP in COPD using cardiovascular magnetic resonance imaging. Eur Radiol. 2017.
   PubMedGoogle Scholar
• Zhang Z, Wang M, Yang Z, et al. Noninvasive prediction of pulmonary artery pressure and vascular resistance by using cardiac magnetic resonance indices. Int J Cardiol. 2017;227:915–922.
   PubMed Web of Science ®Google Scholar
• Swift AJ, Rajaram S, Condliffe R, et al. Pulmonary artery relative area change detects mild elevations in pulmonary vascular resistance and predicts adverse outcome in pulmonary hypertension. Invest Radiol. 2012;47:571–577.
   PubMed Web of Science ®Google Scholar
• Hagger D, Condliffe R, Woodhouse N, et al. Ventricular mass index correlates with pulmonary artery pressure and predicts survival in suspected systemic sclerosis-associated pulmonary arterial hypertension. Rheumatology (Oxford). 2009;48:1137–1142.
   PubMed Web of Science ®Google Scholar
• Rajaram S, Swift AJ, Capener D, et al. Comparison of the diagnostic utility of cardiac magnetic resonance imaging, computed tomography, and echocardiography in assessment of suspected pulmonary arterial hypertension in patients with connective tissue disease. J Rheumatol. 2012;39:1265–1274.
   PubMed Web of Science ®Google Scholar
• Freed BH, Gomberg-Maitland M, Chandra S, et al. Late gadolinium enhancement cardiovascular magnetic resonance predicts clinical worsening in patients with pulmonary hypertension. J Cardiovasc Magn Reson. 2012;14:11.
   PubMed Web of Science ®Google Scholar
• Swift AJ, Telfer A, Rajaram S, et al. Dynamic contrast–enhanced magnetic resonance imaging in patients with pulmonary arterial hypertension. Pulm Circ. 2014;4:61–70.
   PubMed Web of Science ®Google Scholar
• Swift AJ, Rajaram S, Capener D, et al. Longitudinal and transverse right ventricular function in pulmonary hypertension: cardiovascular magnetic resonance imaging study from the ASPIRE registry. Pulm Circ. 2015;5.
   PubMed Web of Science ®Google Scholar
• van Wolferen SA, Marcus JT, Boonstra A, et al. Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension. Eur Heart J. 2007;28:1250–1257.
   PubMed Web of Science ®Google Scholar
• van de Veerdonk MC, Kind T, Marcus JT, et al. Progressive right ventricular dysfunction in patients with pulmonary arterial hypertension responding to therapy. J Am Coll Cardiol. 2011;58:2511–2519.
   PubMed Web of Science ®Google Scholar
• Mauritz G-J, Marcus JT, Boonstra A, et al. Non-invasive stroke volume assessment in patients with pulmonary arterial hypertension: left-sided data mandatory. J Cardiovasc Magn Reson. 2008;10:51.
   PubMed Web of Science ®Google Scholar
• Jaspers K, Freling HG, van Wijk K, et al. Improving the reproducibility of MR-derived left ventricular volume and function measurements with a semi-automatic threshold-based segmentation algorithm. Int J Cardiovasc Imaging. 2013;29:617–623.
   PubMed Web of Science ®Google Scholar
• Saba TS, Foster J, Cockburn M, et al. Ventricular mass index using magnetic resonance imaging accurately estimates pulmonary artery pressure. Eur Respir J. 2002;20:1519–1524.
   PubMed Web of Science ®Google Scholar
• Roeleveld RJ, Marcus JT, Faes TJC, et al. Interventricular septal configuration at MR imaging and pulmonary arterial pressure in pulmonary hypertension. Radiology. 2005;234:710–717.
   PubMed Web of Science ®Google Scholar
• Reiter G, Reiter U, Kovacs G, et al. Counter-clockwise vortical blood flow in the main pulmonary artery in a patient with patent ductus arteriosus with pulmonary arterial hypertension : a cardiac magnetic resonance imaging case report. BMC Med Imaging. 2016;16:45.
   PubMed Web of Science ®Google Scholar
• Reiter G, Reiter U, Kovacs G, et al. Blood flow vortices along the main pulmonary artery measured with MR imaging for diagnosis of pulmonary hypertension. Radiology. 2015;275:71–79.
   PubMed Web of Science ®Google Scholar
• Reiter G, Reiter U, Kovacs G, et al. Magnetic resonance-derived 3-dimensional blood flow patterns in the main pulmonary artery as a marker of pulmonary hypertension and a measure of elevated mean pulmonary arterial pressure. Circ Cardiovasc Imaging. 2008;1:23–30.
   PubMed Web of Science ®Google Scholar
• Rajaram S, Swift AJ, Capener D, et al. Diagnostic accuracy of contrast-enhanced MR angiography and unenhanced proton MR imaging compared with CT pulmonary angiography in chronic thromboembolic pulmonary hypertension. Eur Radiol. 2012;22:310–317.
   PubMed Web of Science ®Google Scholar
• Wild JM, Marshall H, Bock M, et al. MRI of the lung (1/3): methods. Insights Imaging. 2012;3:345–353.
   PubMedGoogle Scholar
• Ohno Y, Hatabu H, Murase K, et al. Quantitative assessment of regional pulmonary perfusion in the entire lung using three-dimensional ultrafast dynamic contrast-enhanced magnetic resonance imaging: preliminary experience in 40 subjects. J Magn Reson Imaging. 2004;20:353–365.
   PubMed Web of Science ®Google Scholar
• Risse F. MR perfusion of the Lung. In: Kauczor H-U, editor. MRI lung. Berlin (Heidelberg): Springer Berlin Heidelberg; 2009.
   Google Scholar
• Köstler H, Ritter C, Lipp M, et al. Prebolus quantitative MR heart perfusion imaging. Magn Reson Med. 2004;52:296–299.
   PubMed Web of Science ®Google Scholar
• Alexandre J, Saloux E, Dugué AE, et al. Scar extent evaluated by late gadolinium enhancement CMR: a powerful predictor of long term appropriate ICD therapy in patients with coronary artery disease. J Cardiovasc Magn Reson. 2013;15:12.
   PubMed Web of Science ®Google Scholar
• Swift AJ, Rajaram S, Capener D, et al. LGE patterns in pulmonary hypertension do not impact overall mortality. JACC Cardiovasc Imaging. 2014;7:1209–1217.
   PubMed Web of Science ®Google Scholar
• Blyth KG, Groenning BA, Martin TN, et al. Contrast enhanced-cardiovascular magnetic resonance imaging in patients with pulmonary hypertension. Eur Heart J. 2005;26:1993–1999.
   PubMed Web of Science ®Google Scholar
• Spruijt OA, Vissers L, Bogaard H-J, et al. Increased native T1-values at the interventricular insertion regions in precapillary pulmonary hypertension. Int J Cardiovasc Imaging. 2016;32:451–459.
   PubMed Web of Science ®Google Scholar
• Jellis CL, Yingchoncharoen T, Gai N, et al. Correlation between right ventricular T1 mapping and right ventricular dysfunction in non-ischemic cardiomyopathy. Int J Cardiovasc Imaging. 2017.
   PubMedGoogle Scholar
• Auger WR, Fedullo P, Peterson K. Chronic major-vessel thomboembolic pulmonary artery obstruction: appearance at anglography. Radiology. 1992;182:393–398.
   PubMed Web of Science ®Google Scholar
• Ogo T. Balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension. Curr Opin Pulm Med. 2015;21:p425–31.
   PubMed Web of Science ®Google Scholar
• Andreassen AK, Ragnarsson A, Gude E, et al. Balloon pulmonary angioplasty in patients with inoperable chronic thromboembolic pulmonary hypertension. Heart. 2013;99:1415–1420.
   PubMed Web of Science ®Google Scholar
• Kataoka M, Inami T, Hayashida K, et al. Percutaneous transluminal pulmonary angioplasty for the treatment of chronic thromboembolic pulmonary hypertension. Circ Cardiovasc Interv. 2012;5:756–762.
   PubMed Web of Science ®Google Scholar
• Fukui S, Ogo T, Morita Y, et al. Right ventricular reverse remodelling after balloon pulmonary angioplasty. Eur Respir J. 2014;43:1394–1402.
   PubMed Web of Science ®Google Scholar
• Quadery S, Billings C, Wild J, et al. Chronic thrombo-embolic pulmonary hypertension: long-term outcomes in operated and non-operated patients. Eur Respir J. 2016;48.
   Google Scholar
• Jorge E, Baptista R, Calisto J, et al. Optical coherence tomography of the pulmonary arteries: a systematic review. J Cardiol. 2016;67:6–14.
   PubMed Web of Science ®Google Scholar
• Dai Z, Fukumoto Y, Tatebe S, et al. OCT imaging for the management of pulmonary hypertension. JACC Cardiovasc Imaging. 2014;7:843–845.
   PubMed Web of Science ®Google Scholar
• Hou J, Qi H, Zhang M, et al. Pulmonary vascular changes in pulmonary hypertension: optical coherence tomography findings. Circ Cardiovasc Imaging. 2010;3:344–345.
   PubMed Web of Science ®Google Scholar
• Dai Z, Sugimura K, Fukumoto Y, et al. Visualization of complete regression of pulmonary arterial remodeling on optical coherence tomography in a patient with pulmonary arterial hypertension. Circ J. 2014;78:2771–2773.
   PubMed Web of Science ®Google Scholar
• Tatebe S, Fukumoto Y, Sugimura K, et al. Optical coherence tomography as a novel diagnostic tool for distal type chronic thromboembolic pulmonary hypertension. Circ J. 2010;74:1742–1744.
   PubMed Web of Science ®Google Scholar
• Hong C, Wang W, Zhong N, et al. Visualization of peripheral pulmonary artery red thrombi utilizing optical coherence tomography. Korean J Radiol. 2013;14:854.
   PubMed Web of Science ®Google Scholar
• D’Alonzo GE, Barst RJ, Ayres SM, et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med. 1991;115:343–349.
   PubMed Web of Science ®Google Scholar
• McLaughlin VV, Presberg KW, Doyle RL, et al. Prognosis of pulmonary arterial hypertension*. Chest. 2004;126:78S–92S.
   PubMed Web of Science ®Google Scholar
• Miyamoto S, Nagaya N, Satoh T, et al. Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing. Am J Respir Crit Care Med. 2000;161:487–492.
   PubMed Web of Science ®Google Scholar
• Sitbon O, Humbert M, Nunes H, et al. Long-term intravenous epoprostenol infusion in primary pulmonary hypertension. J Am Coll Cardiol. 2002;40:780–788.
   PubMed Web of Science ®Google Scholar
• Billings CG, Hurdman JA, Condliffe R, et al. Incremental shuttle walk test distance and autonomic dysfunction predict survival in pulmonary arterial hypertension. J Heart Lung Transplant. 2017;36:871–879.
   PubMed Web of Science ®Google Scholar
• Rubin LJ. The 6-minute walk test in pulmonary arterial hypertension: how far is enough? Am J Respir Crit Care Med. 2012;186:396–397.
   PubMed Web of Science ®Google Scholar
• Demir R, Küçükoğlu MS. Six-minute walk test in pulmonary arterial hypertension. Anatol J Cardiol. 2015;15:249–254.
   PubMed Web of Science ®Google Scholar
• Forfia PR, Fisher MR, Mathai SC, et al. Tricuspid annular displacement predicts survival in pulmonary hypertension. Am J Respir Crit Care Med. 2006;174:1034–1041.
   PubMed Web of Science ®Google Scholar
• Tei C, Dujardin KS, Hodge DO, et al. Doppler echocardiographic index for assessment of global right ventricular function. J Am Soc Echocardiogr. 1996;9:838–847.
   PubMedGoogle Scholar
• Yeo TC, Dujardin KS, Tei C, et al. Value of a Doppler-derived index combining systolic and diastolic time intervals in predicting outcome in primary pulmonary hypertension. Am J Cardiol. 1998;81:1157–1161.
   PubMed Web of Science ®Google Scholar
• Raymond RJ, Hinderliter AL, Willis PW, et al. Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension. J Am Coll Cardiol. 2002;39:1214–1219.
   PubMed Web of Science ®Google Scholar
• Nagaya N, Nishikimi T, Uematsu M, et al. Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension. Circulation. 2000;102:865–870.
   PubMed Web of Science ®Google Scholar
• van Wolferen SA, van de Veerdonk MC, Mauritz G-J, et al. Clinically significant change in stroke volume in pulmonary hypertension. Chest. 2011;139:1003–1009.
   PubMed Web of Science ®Google Scholar
• Peacock AJ, Vonk Noordegraaf A. Cardiac magnetic resonance imaging in pulmonary arterial hypertension. Eur Respir Rev. 2013;22:526–534.
   PubMedGoogle Scholar
• Swift AJ, Rajaram S, Campbell MJ, et al. Prognostic value of cardiovascular magnetic resonance imaging measurements corrected for age and sex in idiopathic pulmonary arterial hypertension. Circ Cardiovasc Imaging. 2014;7:100–106.
   PubMed Web of Science ®Google Scholar
• Baggen VJM, Leiner T, Post MC, et al. Cardiac magnetic resonance findings predicting mortality in patients with pulmonary arterial hypertension: a systematic review and meta-analysis. Eur Radiol. 2016;26:3771–3780.
   PubMed Web of Science ®Google Scholar
• Simonneau G, Rubin LJ, Galiè N, et al. Addition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension: a randomized trial. Ann Intern Med. 2008;149:521–530.
   PubMed Web of Science ®Google Scholar
• Barst RJ, Rubin LJ, Long WA, et al. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. N Engl J Med. 1996;334:296–301.
   PubMed Web of Science ®Google Scholar
• Billings C, Hurdman J, Condliffe R, et al. S121 the utility of the incremental shuttle walking test in pulmonary hypertension: results from the aspire registry. Thorax. 2014;69:A65–A65.
   Web of Science ®Google Scholar
• Leuchte HH, Holzapfel M, Baumgartner RA, et al. Characterization of brain natriuretic peptide in long-term follow-up of pulmonary arterial hypertension. Chest. 2005;128:2368–2374.
   PubMed Web of Science ®Google Scholar
• Casserly B, Klinger JR. Brain natriuretic peptide in pulmonary arterial hypertension: biomarker and potential therapeutic agent. Drug Des Devel Ther. 2009;3:269–287.
   PubMed Web of Science ®Google Scholar
• van de Veerdonk MC, Marcus JT, Westerhof N, et al. Signs of right ventricular deterioration in clinically stable patients with pulmonary arterial hypertension. Chest. 2015;147:1063–1071.
   PubMed Web of Science ®Google Scholar
• Mazurek JA, Vaidya A, Mathai SC, et al. Follow-up tricuspid annular plane systolic excursion predicts survival in pulmonary arterial hypertension. Pulm Circ. 2017;7:361–371.
   PubMed Web of Science ®Google Scholar
• Wright LM, Dwyer N, Celermajer D, et al. Follow-up of pulmonary hypertension with echocardiography. JACC Cardiovasc Imaging. 2016;9:733–746.
   PubMed Web of Science ®Google Scholar
• Bossone E, D’Andrea A, D’Alto M, et al. Echocardiography in pulmonary arterial hypertension: from diagnosis to prognosis. J Am Soc Echocardiogr. 2013;26:1–14.
   PubMed Web of Science ®Google Scholar
• Yorke J, Corris P, Gaine S, et al. emPHasis-10: development of a health-related quality of life measure in pulmonary hypertension. Eur Respir J. 2014;43:1106–1113.
   PubMed Web of Science ®Google Scholar
• Dawes TJW, de Marvao A, Shi W, et al. Machine learning of three-dimensional right ventricular motion enables outcome prediction in pulmonary hypertension: a cardiac MR imaging study. Radiology. 2017;283:381–390.
   PubMed Web of Science ®Google Scholar
• Lungu A, Wild JM, Capener D, et al. MRI model-based non-invasive differential diagnosis in pulmonary hypertension. J Biomech. 2014;47:2941–2947.
   PubMed Web of Science ®Google Scholar